What changed, with dates
Your options now
What changed on this page. Until 4 October 2026 this page said new patients could get free Farxiga through AZ&Me, and carried a "verified 23 August 2026" note. That was wrong: the programme had stopped taking new Farxiga patients on May 1, 2026. The page now reflects AstraZeneca's programme update.
Nothing on this page is medical advice. Do not stop or switch a medicine without talking to your prescriber.
Covered Medications
AZ&Me still covers other AstraZeneca medicines (Farxiga is not among them for new patients):
See the AZ&Me programme page for the full list and income limits.
Check If You Qualify
Use our free Assistance Finder to look for independent foundations and other programmes that may help with the cost of your diabetes, heart or kidney medicines.
Open Assistance FinderSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
- Medicare Plan Compare is the official tool for checking what a specific plan charges for a specific drug at a specific pharmacy.
- Drugs@FDA is the federal database of approved drug products, which establishes whether a covered product exists and in what form.
- DailyMed carries the current FDA labeling for every marketed drug product, including approved strengths and forms.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medication is and how it is used.
- FTC report on pharmacy benefit managers documents how the middlemen between an insurer and a pharmacy shape what a plan actually covers.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Not as a new patient. AstraZeneca's AZ&Me programme stopped accepting new Farxiga patients on May 1, 2026, after generic dapagliflozin became available. Patients already enrolled keep receiving Farxiga until December 31, 2026; the last day to request a refill is December 15, 2026, and AstraZeneca says there are no extensions. Ask your prescriber or pharmacist about generic dapagliflozin, and check independent foundations for help with costs.
Three routes, depending on coverage. Commercially insured patients can use the Farxiga savings card, which AstraZeneca says can bring brand-name Farxiga to as low as $0 a month, subject to eligibility and a monthly savings limit; it is not available to government-insured patients. AstraZeneca Direct sells Farxiga for direct purchase at $35 per 30 tablets to eligible patients. Generic dapagliflozin has been available since April 2026, according to AstraZeneca.
Farxiga is FDA-approved for type 2 diabetes, heart failure and chronic kidney disease. The savings card applies to brand-name Farxiga prescribed for an approved use.
Related Resources
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.